C12Y 304/21048
Cerevisin
Official title: Cerevisin (3.4.21.48)
C12Y304/21048 (Cerevisin) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 6
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 5 Sep 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 2 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Method for manufacturing protein5 Sep 2023US 11,746,342 B2Ajinomoto Co., Inc.
- Compositions and methods for treating celiac sprue disease18 May 2021US 11,008,558 B2University of Washington
- Compositions and methods for treating celiac sprue disease26 Nov 2019US 10,487,318 B1University of Washington through its Center for Commercialization
- Compositions and methods for treating celiac sprue disease23 Apr 2019US 10,266,815 B2University of Washington through its Center for Commercialization
- Sugar-chain modified yeast and method for producing glycoprotein using the same28 Apr 2015US 9,017,969 B2National Institute of Advanced Industrial Science and Technology
- Compositions and Methods for Treating Celiac Sprue Disease16 May 2024US 2024/0158774 A1University of Washington through its Center for Commercialization
- Compositions and Methods for Treating Celiac Sprue Disease12 Aug 2021US 2021/0246437 A1
- Method for Manufacturing Protein13 Aug 2020US 2020/0255869 A1Ajinomoto Co., Inc.
- Compositions and Methods for Treating Celiac Sprue Disease23 Apr 2020US 2020/0123521 A1University of Washington through its Center for Commercialization
- Compositions and Methods for Treating Celiac Sprue Disease7 Jul 2016US 2016/0194621 A1University of Washington through its Center for Commercialization
Most cited
By later US patents
- Compositions and methods for treating celiac sprue disease4US 10,266,815 B2University of Washington through its Center for Commercialization · 2019
- Compositions and methods for treating celiac sprue disease4US 10,487,318 B1University of Washington through its Center for Commercialization · 2019
- Method for manufacturing protein1US 11,746,342 B2Ajinomoto Co., Inc. · 2023